+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biosimilars And Biosuperiors Market Research Reports

Pegfilgrastim Biosimilars Market Report 2025 - Product Thumbnail Image

Pegfilgrastim Biosimilars Market Report 2025

  • Report
  • March 2025
  • 250 Pages
  • Global
From
Remicade Biosimilar Market Report 2025 - Product Thumbnail Image

Remicade Biosimilar Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Biologic & Biosimilar RA Drugs Market Report 2025 - Product Thumbnail Image

Biologic & Biosimilar RA Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Humira Biosimilar Global Market Report 2025 - Product Thumbnail Image

Humira Biosimilar Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
Biobetters - Global Strategic Business Report - Product Thumbnail Image

Biobetters - Global Strategic Business Report

  • Report
  • August 2025
  • 488 Pages
  • Global
From
Biosimilars - Global Strategic Business Report - Product Thumbnail Image

Biosimilars - Global Strategic Business Report

  • Report
  • August 2025
  • 193 Pages
  • Global
From
Bevacizumab - Biosimilar Insight, 2025 - Product Thumbnail Image

Bevacizumab - Biosimilar Insight, 2025

  • Report
  • April 2025
  • 80 Pages
  • Global
From
From
Biosimilar Market Report 2025-2033 - Product Thumbnail Image

Biosimilar Market Report 2025-2033

  • Report
  • January 2025
  • 123 Pages
  • Global
From
From
Biosimilars Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Biosimilars Market - Forecasts from 2025 to 2030

  • Report
  • May 2025
  • 142 Pages
  • Global
From
Biosimilars Market 2025-2029 - Product Thumbnail Image

Biosimilars Market 2025-2029

  • Report
  • February 2025
  • 219 Pages
  • Global
From
Loading Indicator

The Biosimilars and Biosuperiors market is a rapidly growing sector of the pharmaceutical industry. Biosimilars are biologic drugs that are highly similar to an existing biologic drug, while biosuperiors are biologic drugs that are more effective than an existing biologic drug. Biosimilars and biosuperiors are used to treat a variety of conditions, including cancer, autoimmune diseases, and inflammatory diseases. Biosimilars and biosuperiors are developed using advanced biotechnology techniques, such as recombinant DNA technology and monoclonal antibody technology. These drugs are designed to be more cost-effective than their original counterparts, while still providing the same therapeutic benefits. The Biosimilars and Biosuperiors market is expected to continue to grow in the coming years, as more biologic drugs are developed and approved for use. Companies in this market include Amgen, Pfizer, Merck, and Novartis. Show Less Read more